These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 7595220)

  • 1. Interleukin (IL) 4, in the absence of antigen stimulation, induces an anergy-like state in differentiated CD8+ TC1 cells: loss of IL-2 synthesis and autonomous proliferation but retention of cytotoxicity and synthesis of other cytokines.
    Sad S; Mosmann TR
    J Exp Med; 1995 Nov; 182(5):1505-15. PubMed ID: 7595220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine-deficient CD8+ Tc1 cells induced by IL-4: retained inflammation and perforin and Fas cytotoxicity but compromised long term killing of tumor cells.
    Sad S; Li L; Mosmann TR
    J Immunol; 1997 Jul; 159(2):606-13. PubMed ID: 9218575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of Th1 and Tc1 cell adenosine A2A receptors directly inhibits IL-2 secretion in vitro and IL-2-driven expansion in vivo.
    Erdmann AA; Gao ZG; Jung U; Foley J; Borenstein T; Jacobson KA; Fowler DH
    Blood; 2005 Jun; 105(12):4707-14. PubMed ID: 15746085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional characterization and modulation of cytokine production by CD8+ T cells from human immunodeficiency virus-infected individuals.
    Maggi E; Manetti R; Annunziato F; Cosmi L; Giudizi MG; Biagiotti R; Galli G; Zuccati G; Romagnani S
    Blood; 1997 May; 89(10):3672-81. PubMed ID: 9160672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of polarized antigen-specific CD8 effector populations: reciprocal action of interleukin (IL)-4 and IL-12 in promoting type 2 versus type 1 cytokine profiles.
    Croft M; Carter L; Swain SL; Dutton RW
    J Exp Med; 1994 Nov; 180(5):1715-28. PubMed ID: 7525836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD8Tc1 and Tc2 cells secrete distinct cytokine patterns in vitro and in vivo but induce similar inflammatory reactions.
    Li L; Sad S; Kägi D; Mosmann TR
    J Immunol; 1997 May; 158(9):4152-61. PubMed ID: 9126975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-15 induces type 1 and type 2 CD4+ and CD8+ T cells proliferation but is unable to drive cytokine production in the absence of TCR activation or IL-12 / IL-4 stimulation in vitro.
    Niedbala W; Wei X; Liew FY
    Eur J Immunol; 2002 Feb; 32(2):341-7. PubMed ID: 11807773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tc1 and Tc2 effector cell therapy elicit long-term tumor immunity by contrasting mechanisms that result in complementary endogenous type 1 antitumor responses.
    Dobrzanski MJ; Reome JB; Hollenbaugh JA; Dutton RW
    J Immunol; 2004 Feb; 172(3):1380-90. PubMed ID: 14734713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-CD3-induced anergy in cloned human Th0, Th1, and Th2 cells.
    Nguyen DD; Beck L; Spiegelberg HL
    Cell Immunol; 1995 Oct; 165(1):153-7. PubMed ID: 7671320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ex vivo rapamycin generates Th1/Tc1 or Th2/Tc2 Effector T cells with enhanced in vivo function and differential sensitivity to post-transplant rapamycin therapy.
    Jung U; Foley JE; Erdmann AA; Toda Y; Borenstein T; Mariotti J; Fowler DH
    Biol Blood Marrow Transplant; 2006 Sep; 12(9):905-18. PubMed ID: 16920556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single human T cells stimulated in the absence of feeder cells transcribe interleukin-2 and undergo long-term clonal growth in response to defined monoclonal antibodies and cytokine stimulation.
    Sunder-Plassmann R; Breiteneder H; Zimmermann K; Strunk D; Majdic O; Knapp W; Holter W
    Blood; 1996 Jun; 87(12):5179-84. PubMed ID: 8652831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Augmentation of naive, Th1 and Th2 effector CD4 responses by IL-6, IL-1 and TNF.
    Joseph SB; Miner KT; Croft M
    Eur J Immunol; 1998 Jan; 28(1):277-89. PubMed ID: 9485207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression and costimulatory effect of 4-1BB (CD137) and CD28 molecules on cytokine-induced murine CD8(+) Tc1 and Tc2 cells.
    Vinay DS; Kwon BS
    Cell Immunol; 1999 Feb; 192(1):63-71. PubMed ID: 10066348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of IL-2, IL-4 and IL-6 in the growth and differentiation of tumor-specific CD4+ T helper and CD8+ T cytotoxic cells.
    Selvan RS; Nagarkatti PS; Nagarkatti M
    Int J Cancer; 1990 Jun; 45(6):1096-104. PubMed ID: 1972141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo priming of CD4 T cells that produce interleukin (IL)-2 but not IL-4 or interferon (IFN)-gamma, and can subsequently differentiate into IL-4- or IFN-gamma-secreting cells.
    Wang X; Mosmann T
    J Exp Med; 2001 Oct; 194(8):1069-80. PubMed ID: 11602637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-12 primes human CD4 and CD8 T cell clones for high production of both interferon-gamma and interleukin-10.
    Gerosa F; Paganin C; Peritt D; Paiola F; Scupoli MT; Aste-Amezaga M; Frank I; Trinchieri G
    J Exp Med; 1996 Jun; 183(6):2559-69. PubMed ID: 8676077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human Tc1 and Tc2/Tc0 CD8 T-cell clones display distinct cell surface and functional phenotypes.
    Vukmanovic-Stejic M; Vyas B; Gorak-Stolinska P; Noble A; Kemeny DM
    Blood; 2000 Jan; 95(1):231-40. PubMed ID: 10607707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry.
    Berner B; Akça D; Jung T; Muller GA; Reuss-Borst MA
    J Rheumatol; 2000 May; 27(5):1128-35. PubMed ID: 10813277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The phenotype of type 1 and type 2 CD8+ T cells activated in vitro is affected by culture conditions and correlates with effector activity.
    Kemp RA; Bäckström BT; Ronchese F
    Immunology; 2005 Jul; 115(3):315-24. PubMed ID: 15946249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxicity and weak CD40 ligand expression of CD8+ type 2 cytotoxic T cells restricts their potential B cell helper activity.
    Sad S; Krishnan L; Bleackley RC; Kägi D; Hengartner H; Mosmann TR
    Eur J Immunol; 1997 Apr; 27(4):914-22. PubMed ID: 9130644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.